Trinidad and Tobago

Resilience System


Indonesia faces coronavirus catastrophe , Red Cross warns.

COVID-19 now surging in vulnerable Africa rural areas

ANALYIS: COVID Delta variant takeover in U.K. offers a warning, and some hope

Germany catches up with the United States in terms of the proportion of the population with a first COVID-19 vaccination

France delays some regional relaxing of COVID restrictions as concerns grow over fourth wave

OVERVIEW: U.S. Military, Asia, South Pacific developments

 -- Members of the U.S. military who were vaccinated against COVID-19 showed higher-than-expected rates of heart inflammation, although the condition was still extremely rare, according to a study released on Tuesday.

Problem, Solution, SitRep, or ?: 

MASKS: Three articles on reconsideration of masks as precautions

 

Throughout the pandemic, masks have ranked among the most contentious public health measures in the United States, symbolizing a bitter partisan divide over the role of government and individual liberties.

Now, with a new variant of the coronavirus rapidly spreading across the globe, masks are again the focus of conflicting views, and fears, about the course of pandemic and the restrictions required to manage it.

Country / Region Tags: 
Problem, Solution, SitRep, or ?: 

The simple text message seems to work best in encourging people to get vaccinated--new study

Delta variant continues to spread, prompting new restrictions worldwide

Webinar: Drones for use by first responders in emergencies, Wed, Jun 30, 2021, 3:00 PM EDT

Moderna says COVID-19 vaccine performed well in a small lab study against delta variant

Russia's Sputnik V vaccine only slightly less effective against Delta variant, developers say

MOSCOW (Reuters) -Russia’s Sputnik V vaccine against COVID-19 is around 90% effective against the highly contagious Delta variant of coronavirus, its developers said on Tuesday.

Country / Region Tags: 
Problem, Solution, SitRep, or ?: 

EU aviation industry warns lack of coordination with COVID certificats could cause chaos at airports

OVERVIEW: Australia, U.S. Europe, cruise line

Three studies offered fresh evidence that widely used vaccines will continue to protect people against the coronavirus for long periods

Three scientific studies released on Monday offered fresh evidence that widely used vaccines will continue to protect people against the coronavirus for long periods, possibly for years, and can be adapted to fortify the immune system still further if needed.

Most people immunized with the mRNA vaccines may not need boosters, one study found, so long as the virus and its variants do not evolve much beyond their current forms — which is not guaranteed. Mix-and-match vaccination shows promise, a second study found, and booster shots of one widely used vaccine, if they are required, greatly enhance immunity, according to a third report.

Problem, Solution, SitRep, or ?: 

Pages

Subscribe to Trinidad and Tobago RSS
howdy folks
Page loaded in 1.233 seconds.